Free Trial
CVE:KNE

Kane Biotech (KNE) Stock Price, News & Analysis

Kane Biotech logo
C$0.08 0.00 (0.00%)
As of 02:24 PM Eastern

About Kane Biotech Stock (CVE:KNE)

Key Stats

Today's Range
C$0.08
C$0.08
50-Day Range
C$0.08
C$0.12
52-Week Range
C$0.08
C$0.17
Volume
70,315 shs
Average Volume
49,816 shs
Market Capitalization
C$11.52 million
P/E Ratio
2.00
Dividend Yield
3.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.

Receive KNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter.

KNE Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
See More Headlines

KNE Stock Analysis - Frequently Asked Questions

Kane Biotech's stock was trading at C$0.11 on January 1st, 2025. Since then, KNE stock has decreased by 27.3% and is now trading at C$0.08.
View the best growth stocks for 2025 here
.

Shares of KNE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kane Biotech investors own include Mason Resources (LLG), Datametrex AI (DM) and Allstar Health Brands (ALST).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:KNE
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
2.00
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$6.03 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.42 million
Cash Flow
C$0.01 per share
Price / Cash Flow
8.50
Book Value
C($0.01) per share
Price / Book
-15.54

Miscellaneous

Free Float
N/A
Market Cap
C$11.52 million
Optionable
Not Optionable
Beta
0.52
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (CVE:KNE) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners